好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Florbetapir F 18 PET Imaging and CSF Biomarkers Provide Concordant Measures of Underlying Brain Amyloid Pathology and Cognitive Performance
Aging and Dementia
(-)
004
Authors/Disclosures
Michael J. Pontecorvo, PhD (Avid Radiopharmaceuticals) Dr. Pontecorvo has received personal compensation for serving as an employee of Eli Lilly. Dr. Pontecorvo has stock in Eli Lilly.
Christopher Clark, MD (Avid Radiopharmaceuticals) No disclosure on file
No disclosure on file
Eva K. Ritzl, MD, MBA, FRCP (Glasgow), FAAN (Massachusetts General Brigham (MGB)) Dr. Ritzl has a non-compensated relationship as a Advocacy committee co-chair and CPT and RUC representation with ACNS that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Health Policy committee member with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a AAN HOD Alternate Delegate with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Epic Neurosciences steering board with Epic that is relevant to AAN interests or activities.
No disclosure on file
Daniel Skovronsky, MD, PhD No disclosure on file
Mark A. Mintun, MD Dr. Mintun has received personal compensation for serving as an employee of Eli Lilly & Co.